Essentially, CYDY argues that the 13D BOD nominati
Post# of 148277
Quote:
Essentially, CYDY argues that the 13D BOD nominating notice, delivered at the 11th hour timing wise, contained several material deficiencies, chiefly exemplified by the Incell proposed sale and patent application omissions, which were in violation of CYDY's corporate bylaws and justify disqualification of the 13D slate of candidates.
What might carry heavier weight with the court than it violating the bylaws is that it is also in violation of SEC regulations in section 240.14a–101 regarding disclosure of conflicts of interest.